Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
125 studies found for:    "Speech Disorders"
Show Display Options
Rank Status Study
21 Enrolling by invitation A Composite MR Neuroimaging Marker for Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment;   Frontotemporal Dementia
Intervention:
22 Recruiting Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia
Conditions: Aphasia;   Stroke;   Cerebrovascular Accident;   Apoplexy;   Cerebral Infarction
Interventions: Behavioral: Melodic Intonation Therapy;   Behavioral: Speech-Repetition-Therapy
23 Recruiting Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
Condition: Post-stroke Aphasia
Intervention: Device: TNM(trademark) - thermoneuromodulation
24 Terminated Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Conditions: Acid Sphingomyelinase Deficiency;   Niemann-Pick Disease
Intervention: Drug: rhASM
25 Recruiting Cerebellar Mutism Syndrome Study
Conditions: Infratentorial Neoplasms;   Mutism
Intervention:
26 Completed Integrated Behavioral Therapy for Treating Children With Selective Mutism
Condition: Selective Mutism
Intervention: Behavioral: Integrated behavioral therapy (BT)
27 Completed Memantine and Intensive Speech-Language Therapy in Aphasia
Conditions: Aphasia;   Stroke
Interventions: Drug: memantine;   Behavioral: constraint-induced language therapy (CIAT);   Drug: placebo
28 Terminated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Conditions: Frontotemporal Dementia;   Amyotrophic Lateral Sclerosis
Intervention:
29 Not yet recruiting Clinical Utility of Flutemetamol in the Differential Diagnosis and Prognosis of Alzheimer's and Frontotemporal Dementia
Conditions: Alzheimer's Disease;   Frontotemporal Dementia
Intervention: Drug: Flutemetamol
30 Completed
Has Results
What Treatment Works for Children With Selective Mutism?
Condition: Selective Mutism
Intervention: Behavioral: Interventions at home, in the kindergarten/school
31 Unknown  Improvement of Language Disturbances After Stroke by Intensive Training and Electrical Brain Stimulation
Conditions: Aphasia;   Stroke
Interventions: Device: anodal tDCS;   Device: cathodal tDCS;   Device: sham stimulation
32 Enrolling by invitation Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
Conditions: Alzheimer's Disease;   Behavioral Variant Frontotemporal Dementia
Intervention: Drug: TRx0237
33 Recruiting Living With Frontotemporal Dementia
Condition: Adaptation
Intervention:
34 Recruiting Brain Stimulation and Aphasia Treatment
Condition: Aphasia
Interventions: Device: Activa Dose II Real tDCS;   Device: Activa Dose II Sham tDCS
35 Not yet recruiting Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects
Condition: Familial Frontotemporal Dementia
Intervention:
36 Suspended A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Condition: Stuttering
Intervention: Drug: Asenapine
37 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
38 Completed Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
Conditions: Memory Disorders;   Alzheimer Disease;   Dementia;   Cognitive Impairment;   Frontotemporal Dementia
Intervention: Device: COGNISION™ System
39 Completed Effect of Dopaminergic Medication on Recovery of Aphasia
Condition: Aphasia
Interventions: Drug: levodopa and benserazide;   Drug: placebo
40 Not yet recruiting Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years